Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argosy Private Equity is a private equity investment firm specializing in lower middle market businesses across the United States. It invests primarily in advanced manufacturing, business services, and select healthcare companies. The firm's Value Acceleration Methodology (VAM™) focuses on revenue growth, operational improvements, and professionalization of portfolio companies. As of 2024, it manages over $1 billion in assets under management within its private equity division and has completed more than 135 platform investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argosy Private Equity.